Shaw-Jenq Tsai Lab

Lab Director

Shaw-Jenq Sean Tsai, Chair Professor

B.S. National Cheng-Kung University 1982-1986
M.S. Eastern Michigan University 1990-1992
Ph.D. University of Wisconsin-Madison 1993-1997
Joined Cheng Kung University Faculty 1998
Assistant Professor 1998-2002
Associate Professor 2002-2005
Professor 2005-2008
Distinguished Professor 2008-2019
Chair Professor 2019-
Visiting Professor, Baylor College of Medicine 2010-2011
Director General, Ministry of Science and Technology 2014-2017
Ambassador, World Endometriosis Society 2014-
President, The Chinese Physiological Society 2016-
Councilor, Society for Experimental Biology and Medicine 2018-
President, Asian Society for Endometriosis and Adenomyosis 2019-
Education and Experience:

Office: +886-6-2353535 ext.5426
Laboratory:+886-6-2353535 ext.5429
82-0701 Basic Medical Science Building

  • Speciality: 

    Translational Medicine、Bioinformatics、Cancer Biology、Endometriosis

  • Award: 

    * National Science Council: Distinguished Research Award (2011)
    * Society for Experimental and Biology (SEBM): Distinguished Scientist Award (2014)
    *Ministry of Science and Technology: Distinguished Research Award (2018)
    *Society for Experimental Biology and Medicine:Fellow (2018)
    *American Association for Cancer Research: Most-Cited Article Published in 2017 Cancer Research (2019)
    *Fuller W. Bazer SSR International Scientist Award (2020)

  • Research interests:

    My research interests focus on understanding the molecular mechanisms of human diseases. Our studies could be divided into two areas:

    1. Endometriosis

    Endometriosis is a common gynecological disease with the prevalence of 10-15 %. It is a complex disease with unknown etiology and severely reduces life quality of affected women and their family. We focus on local and epigenetic factors that cause inflammation in the peritoneal cavity, aberrant production of steroid hormones, angiogenesis, and suppression of immune function.

    2. Cancer

    Drug resistance is the most critical issue that contributes to treatment failure and mortality. Hypoxia is one of the most critical factors contributing to drug resistance. However, mechanisms responsible for hypoxia-mediated increased in drug resistance remain largely unknown. We have employed systems biology approach to investigate effects of hypoxia-mediated gene regulatory networks in drug resistance and cancer malignancy.

  • News:
    1. (2008) The EBM Journal Asia Office was established at the National Cheng Kung University 

    2. (2014) Distinguished Scientist Award 

    3.(2020)Fuller W. Bazer SSR International Scientist Award